Understanding, Therapeutic Misconceptions and Perceptions, and Enrollment Decision-Making: A Pediatric Preventive...

Area of Science:

• Clinical Research Ethics
• Infectious Disease Epidemiology
• Global Health

Background:

• Informed consent in clinical trials is crucial, especially in developing countries.
• Concerns exist regarding limited understanding and potential exploitation undermining consent.
• Qualitative research is needed to explore participant understanding and decision-making.

Purpose of the Study:

• To investigate the relationship between maternal understanding of research and infant enrollment decisions in the Kili IPTi trial.
• To address concerns about informed consent in international clinical research.
• To identify factors influencing decisions to participate or decline in pediatric malaria prevention trials.

Main Methods:

• Conducted extensive qualitative interviews with mothers invited to enroll infants in the Kili IPTi trial.
• Analyzed interview data to explore understanding of research concepts and decision-making factors.
• Compared understanding levels between mothers who enrolled infants and those who declined.

Main Results:

• Mothers who declined infant participation demonstrated a superior understanding of the trial's experimental nature.
• Decliners were less likely to exhibit "therapeutic misconception" (confusing research with treatment).
• Neither participants nor decliners cited altruistic motivations; ancillary benefits influenced perceptions of clinical benefit.

Conclusions:

• Maternal understanding of research is a critical factor in informed consent for clinical trials.
• Enhanced strategies are needed to ensure genuine understanding, not just consent, in research participation.
• The study highlights the complexity of decision-making, influenced by perceived benefits beyond altruism.